2024
|
G/S
|
Physio therapy. |
|
G/S
|
Logiciels téléchargeables sous forme d'applications mobiles pour le traitement de la déficience e... |
|
G/S
|
Downloadable software in the form of mobile applications for growth hormone deficiency treatment. |
|
G/S
|
Downloadable software in the form of mobile applications for
growth hormone deficiency treatment. |
|
Invention
|
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators.
The disclosure relates to modul... |
|
Invention
|
Methods of administering fviii mimetic bispecific antibodies once every second month. The present... |
|
G/S
|
Downloadable software in the nature of mobile applications for use in the treatment of growth hor... |
|
G/S
|
Préparations pharmaceutiques pour le traitement d'affections hématologiques, préparations pharmac... |
|
G/S
|
Pharmaceutical preparations for the treatment of hematological conditions, pharmaceutical prepara... |
|
G/S
|
Pharmaceutical preparations for the treatment of
hematological conditions, pharmaceutical prepar... |
2023
|
G/S
|
Logiciel téléchargeable sous forme d'applications mobiles à utiliser dans le traitement de la déf... |
|
G/S
|
Downloadable software in the nature of mobile applications
for use in the treatment of growth ho... |
|
Invention
|
Synthesis of pyrrolo[3,4-c]pyrroles. cce.g.e.g. PKR Activating Compounds). |
|
G/S
|
Downloadable software in the nature of mobile applications for the treatment of growth hormone de... |
|
Invention
|
Methods of administering fviii mimetic bispecific antibodies every second week. The present inven... |
|
Invention
|
Methods of administering fviii mimetic bispecific antibodies once weekly. The present invention g... |
|
Invention
|
Methods of administering fviii mimetic bispecific antibodies once monthly. The present invention ... |
2020
|
Invention
|
Pyruvate kinase r (pkr) activating compositions. The present disclosure provides crystalline soli... |
2018
|
Invention
|
Methods and compositions for inhibiting expression of ldha. This disclosure relates to oligonucle... |
|
Invention
|
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators. The disclosure relates to modula... |
2017
|
Invention
|
Preparation of sugar-nucleotides. The present invention relates to methods for preparation of gly... |
2016
|
Invention
|
Factor xiii for the treatment of interstitial cystitis. The present invention relates to the use ... |
2015
|
Invention
|
Therapeutic inhibition of lactate dehydrogenase and agents therefor. This invention relates to co... |
|
Invention
|
Lysine rich basic pre-sequences. The invention describes novel pre-sequences that assist efficien... |
|
Invention
|
Factor vii conjugates. The present invention, relates to the conjugation of Factor VII polypeptid... |
|
Invention
|
Coagulation factor ix conjugates. The present invention relates to Factor IX polypeptides conjuga... |
2014
|
Invention
|
Method for thioether conjugation of proteins. The invention relates to methods for obtaining a pr... |
|
Invention
|
Coagulation factor vii polypeptides. The present invention relates to modified human coagulation ... |
|
Invention
|
Thiol functionalized polymers. The invention relates to an immobilized reducing agent suited for ... |
|
Invention
|
Growth hormone compound formulation. The present inventions relates to compositions of growth hor... |
|
Invention
|
Growth hormone compounds. The invention relates to growth hormone compounds with a long plasma ha... |
2013
|
Invention
|
Fatty acid acylated amino acids for growth hormone delivery. The present invention relates to gro... |
|
Invention
|
Factor vii conjugates. The present invention relates to the conjugation of Factor VII polypeptide... |
|
Invention
|
Coagulation factor vii polypeptides. The present invention relates to modified coagulation Factor... |
|
Invention
|
Liquid pharmaceutical composition of factor vii polypeptide. The invention concerns a liquid phar... |
|
Invention
|
Liquid pharmaceutical composition of factor vii polypeptide. The invention relates to a liquid, a... |
|
Invention
|
Method of manufacturing a medical device. The invention relates to a method of manufacturing a me... |
|
Invention
|
Fviia-stf complexes exhibiting exosite-mediated super activity. Disclosed are disulphide-linked c... |
2012
|
Invention
|
Medical device having integrated sequence control. The present invention relates to a medical dev... |
|
Invention
|
Barrier element removal. A medical device (1) comprising a frame (2, 3, 6) defining an interior, ... |
|
Invention
|
Sterile spike compartment. The present invention relates to an assembly (100, 200) for a fluid tr... |
|
Invention
|
Pre-assembled fluid transfer arrangement. The present invention relates to a medical device (1, 1... |
|
Invention
|
Piston rod anchoring. A piston assembly having a piston (10) and a piston/piston rod coupling arr... |
2011
|
Invention
|
Piston rod drive system for a drug delivery device. A piston rod drive system is provided compris... |
|
Invention
|
Wheel operated drug delivery device. A drug delivery device (1) for mixing substances and adminis... |
|
Invention
|
Process for protein production. The present invention relates to a process for the production of ... |
|
Invention
|
Growth hormone conjugates. The present invention relates to growth hormone conjugates comprising ... |
|
Invention
|
Factor vii fusion polypeptides. The present invention relates to a Factor VII (FVII) fusion polyp... |
|
Invention
|
Growth hormones with prolonged in-vivo efficacy. The invention relates to growth hormone compound... |
|
Invention
|
Stable growth hormone compounds. The present invention relates to growth hormone (GH) compounds h... |
|
Invention
|
Purification of blood coagulation factors. The present invention relates to the purification of v... |
2010
|
Invention
|
Method of purifying pegylated proteins. The invention relates to a method of purifying PEGylated ... |
|
Invention
|
Growth hormones with prolonged in-vivo efficacy. The present invention relates to polypeptide com... |
|
Invention
|
Mixing device with piston coupling arrangement. A device (1) for mixing substances to obtain an i... |
|
Invention
|
Stable pharmaceutical compositions of peptide derivatized using an oxime linker. The invention re... |
|
Invention
|
Stable growth hormone compounds. The present invention relates to stable growth hormone (GH) comp... |